Navigation Links
Inovio Pharmaceuticals Demonstrates Positive Immune Responses in Phase I Clinical Trial of SynCon™ H5N1 Influenza Vaccine and Launches Multi-Subtype Influenza Vaccine Phase I
Date:7/14/2011

g the influenza A H1N1, H5N1, H3N2, H2N2 subtypes as well as influenza B with the goal of developing a universal influenza vaccine.

About Inovio Pharmaceuticals, Inc.

Inovio is developing a new generation of vaccines, called DNA vaccines, to treat and prevent cancers and infectious diseases. Its SynCon™ vaccines are designed to provide broad cross-strain protection against known as well as newly emergent strains of pathogens such as influenza. These vaccines, in combination with Inovio's proprietary electroporation delivery devices, have been shown to be safe and generate significant immune responses. Inovio clinical programs include three Phase II studies for vaccines treating cervical dysplasia/cancer, hepatitis C virus, and leukemia. Other clinical programs target influenza (preventive) and HIV (preventive and therapeutic). Inovio partners and collaborators include the University of Pennsylvania, Merck, ChronTech, National Cancer Institute, U.S. Military HIV Research Program, NIH, HIV Vaccines Trial Network, University of Southampton, and PATH Malaria Vaccine Initiative. More information is available at www.inovio.com.

This press release contains certain forward-looking statements relating to our business, including our plans to develop electroporation-based drug and gene delivery technologies and DNA vaccines and our capital resources. Actual events or results may differ from the expectations set forth herein as a result of a number of factors, including uncertainties inherent in pre-clinical studies, clinical trials and product development programs (including, but not limited to, the fact that pre-clinical and clinical results referenced in this release may not be indicative of results achievable in other trials or for other indications, that the studies or trials may not be successful or achieve the results desired, that results from one study may not necessarily be reflected or support
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Inovio Pharmaceuticals Announces Transition of Avtar Dhillon to Non-Executive Chairman of the Board
2. Inovio Pharmaceuticals to Present at Scientific & Industry Conferences
3. Inovio Pharmaceuticals Subsidiary, VGX Animal Health, to Present at VetHealth Global 2011, June 14-17, 2011
4. Inovio Pharmaceuticals to Present at American Society of Gene & Cell Therapy Annual Meeting May 18 - 21, 2011
5. Inovio Pharmaceuticals Market-Leading Intellectual Property Recognized by MDB Capital Award
6. Inovio Pharmaceuticals to Present at Investor Conferences
7. Inovio Pharmaceuticals, Transgene and ChronTech Pharma to Collaborate on Heterologous Prime-Boost Therapeutic Vaccination Against Hepatitis C
8. OncoSec Medical Closes Purchase and License Agreement for Tumor Therapy Technology with Inovio Pharmaceuticals
9. Inovio Pharmaceuticals to Present at Scientific Conferences
10. Inovio Pharmaceuticals Receives U.S. DOD Small Business Innovation Research Grant for Multi-Vaccine DNA Delivery Device Development
11. Inovio Pharmaceuticals Reports 2010 Fourth Quarter and Year End Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Quebec, July 31, 2014   , 2014 Second ... the prior year , Overall organic growth was 4% for ... injectable products; Bausch + Lomb grew 12% , 2014 ... of 43% , 2014 Second Quarter GAAP Operating Cash ... , Highlights of the Second Quarter , Launched 17 ...
(Date:7/31/2014)... 2014 Auxilium Pharmaceuticals, Inc. ... company, today announced that the Company will receive ... partner Asahi Kasei Pharma Corporation (Asahi Kasei). The ... of a regulatory application to the Japanese Pharmaceutical ... (collagenase clostridium histolyticum) for the treatment of ...
(Date:7/31/2014)... 2014 MarketResearchreports.biz presents this most ... (Rapid-Acting, Short-Acting, Intermediate-Acting, Long-Acting, Premixed, And Modern and ... and Forecast (Value and Volume), 2013 - 2019: Market ... growing at an exponential rate worldwide, has become a ... major cause of death of people between 20 years ...
Breaking Medicine Technology:Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 2Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 3Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 4Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 5Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 6Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 7Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 8Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 9Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 10Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 11Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 12Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 13Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 14Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 15Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 16Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 17Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 18Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 19Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 20Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 21Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 22Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 23Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 24Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 25Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 26Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 27Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 28Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 29Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 30Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 31Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 32Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 2Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 3Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 4Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 5
... First Pro-Healing Stent Also ... Featured at Annual Symposium, ... the subject of several sessions about,innovation in interventional cardiology strategies ... 2007,which is set for Oct. 20-25 at the Washington Convention ...
... Bono Initiative Aims to Mobilize $25 Million to Eliminate ... Afflicting the Poorest of the Poor, EAST RUTHERFORD, N.J., ... nation,s top ten public relations firms, was,highlighted by President Bill ... for its key role in the fight against diseases of,poverty ...
Cached Medicine Technology:OrbusNeich's Genous(TM) Bio-Engineered R Stent(TM) is Subject of Sessions on Innovation at TCT 2007 2President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its 'Stop Neglected Tropical Disease' Campaign 2President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its 'Stop Neglected Tropical Disease' Campaign 3President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its 'Stop Neglected Tropical Disease' Campaign 4
(Date:7/31/2014)... Controlled application of vacuum pressure is a promising approach ... suggests an experimental study in the August issue of ... Congress of Neurological Surgeons . The journal is ... part of Wolters Kluwer Health . , ... injured area of the brainshows promise as a safe ...
(Date:7/31/2014)... and Las Vegas, Nevada (PRWEB) July 31, 2014 ... LaunchKey to provide next generation authentication services to cloud ... secure way to utilize hardware protected multi-factor authentication with ... in the Internet's reliance on password-based authentication. It is ... global data breaches taking place around the globe. Instead ...
(Date:7/31/2014)... Texas (PRWEB) July 31, 2014 The ... Patient Experience Executive Board and four new members ... strengthening its role as the global community of practice ... in healthcare. , Executive board members are industry ... plans, and provide valuable insight into market and industry ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Web Programming ... ISO 9001:2008 certified internet marketing firm, has recently launched ... to make this service affordable for everyone, the company ... the service. , Web Programming Services has tailored ... world of brochure designing and likely expectations of the ...
(Date:7/31/2014)... Steven Reinberg HealthDay Reporter ... Strict regulation of electronic cigarettes isn,t warranted based on ... the contrary, allowing e-cigarettes to compete with regular cigarettes ... after reviewing 81 prior studies on the use and ... evidence suggests that there is a potential for smokers ...
Breaking Medicine News(10 mins):Health News:Vacuum treatment may limit damage after traumatic brain injury 2Health News:Rivetz Partners with LaunchKey to Offer Next Generation Authentication for Accounts Leveraging Trusted Execution Technology. 2Health News:Rivetz Partners with LaunchKey to Offer Next Generation Authentication for Accounts Leveraging Trusted Execution Technology. 3Health News:The Beryl Institute Announces Seven New Patient Experience Board Members 2Health News:The Beryl Institute Announces Seven New Patient Experience Board Members 3Health News:Web Programming Services Introduces Affordable Brochure Designing Service 2Health News:Benefits of E-Cigarettes May Outweigh Harms, Study Finds 2Health News:Benefits of E-Cigarettes May Outweigh Harms, Study Finds 3
... trigger urge to smoke, researchers say , WEDNESDAY, Sept. 9 ... component in cigarettes, "tricks" the brain into creating memory associations ... why former smokers miss lighting up when they are in ... from researchers at Baylor College of Medicine are in the ...
... response , WEDNESDAY, Sept. 9 (HealthDay News) -- Early day ... and illnesses at an early age, thereby protecting them from ... the ,hygiene hypothesis," but a new study casts doubt on ... asthma and allergy rates at age 8. , An unexplained ...
... , SOUTHFIELD, Mich., Sept. 9 The Wild ... employee health screenings. While national and local regulations cover finger sticks ... national standards and monitors on-site health screenings or flu shot programs. ... approaches, a new white paper from wellness screening provider Summit Health, ...
... PRINCETON, N.J., Sept. 9 From October 5-9, contact center ... Mandalay Bay Convention Center to attend the sixth annual 2009 ... Produced by the International Customer Management Institute (ICMI), this year,s ... the Customer Experience." Intensive, daylong pre-conference summits for financial services ...
... , CHICAGO, Sept. 9 Morrisey ... high-risk, complex patients outside the acute-care setting. , ... (MCCM(TM)) Continuum of Care software enables organizations to extend their ... are able to reduce unnecessary hospital admissions, emergency department visits ...
... , , , SHREVEPORT, La., ... set out on her life-finding mission with a book contract in her pocket. ... giant in Italy, she was just living. She had no notion that what ... , But life took this Louisiana-raised girl and her endearing ...
Cached Medicine News:Health News:Nicotine Plays Tricks on Brain: Study 2Health News:Day Care May Not Shield Kids From Asthma, Allergies 2Health News:Day Care May Not Shield Kids From Asthma, Allergies 3Health News:Summit Health Helps Employers Navigate the 'Wild West' of Flu Shots and Workplace Health Screenings 2Health News:Global Gathering for Contact Center Professionals to Focus On 'Thinking Forward - The Power of the Customer Experience' at ICMI's Annual Call Center Exhibition Conference and Expo, Oct. 5-9 in Las Vegas 2Health News:Global Gathering for Contact Center Professionals to Focus On 'Thinking Forward - The Power of the Customer Experience' at ICMI's Annual Call Center Exhibition Conference and Expo, Oct. 5-9 in Las Vegas 3Health News:Morrisey Associates Helps Healthcare Organizations Improve Patient Management Outside the Acute-Care Setting 2Health News:Exotic Adventure and Clean Food: The Adventure Cookbook 2
... 2000 Pipette is a synonym for pipetting ... robust design, and superior operating comfort. Its ... the measuring stroke and blow-out as well ... system ensures utmost accuracy and precision. Ejection ...
... Remels newest member of the Xpect family, Xpect ... and B in one rapid test. The simple-to-perform ... available in 20 minutes. ,The Remel Xpect family ... range of rapid, direct specimen tests that combine ...
Inquire...
Inquire...
Medicine Products: